Nov. 28 (UPI) -- A new antibiotic could bring hope to people suffering from Alzheimer's and Parkinson's.
After testing the effects of the antibiotic minocycline on older roundworms that had a build-up of α-synuclein and amyloid-β, two proteins associated with Parkinson's and Alzheimer's disease, researchers saw a decrease in the number of aggregation of the two proteins, according to a new study published Tuesday in eLife.